We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+0.99%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$201M
AUM Growth
+$781K
Cap. Flow
+$614K
Cap. Flow %
0.31%
Top 10 Hldgs %
28.32%
Holding
83
New
5
Increased
29
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.11M
2
CVX icon
Chevron
CVX
+$1.91M
3
HD icon
Home Depot
HD
+$1.45M
4
EFX icon
Equifax
EFX
+$1.34M
5
META icon
Meta Platforms (Facebook)
META
+$1.31M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$2.23M
2
CVS icon
CVS Health
CVS
+$2.14M
3
CERN
Cerner Corp
CERN
+$1.89M
4
PPG icon
PPG Industries
PPG
+$1.28M
5
WFC icon
Wells Fargo
WFC
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 26.39%
2 Healthcare 19.5%
3 Industrials 12.44%
4 Consumer Discretionary 8.51%
5 Consumer Staples 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
51
Meta Platforms (Facebook)
META
$1.5T
$1.22M 0.61%
+10,631
New +$1.31M
PSA icon
52
Public Storage
PSA
$61.1B
$1.16M 0.58%
5,181
-3,866
-43% -$823K
CTSH icon
53
Cognizant
CTSH
$25.1B
$1.11M 0.55%
19,737
-500
-2% -$26.8K
BLK icon
54
Blackrock
BLK
$176B
$1.03M 0.51%
2,706
+485
+22% +$178K
JNJ icon
55
Johnson & Johnson
JNJ
$621B
$997K 0.5%
8,651
+75
+0.9% +$8.66K
BKNG icon
56
Booking.com
BKNG
$160B
$924K 0.46%
15,750
+1,050
+7% +$62.7K
BMY icon
57
Bristol-Myers Squibb
BMY
$130B
$818K 0.41%
14,000
LHX icon
58
L3Harris
LHX
$53.3B
$813K 0.41%
+7,933
New +$784K
MAR icon
59
Marriott International
MAR
$94.2B
$785K 0.39%
9,495
+65
+0.7% +$4.89K
NEE icon
60
NextEra Energy
NEE
$179B
$576K 0.29%
19,292
-1,108
-5% -$33.1K
SNI
61
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$558K 0.28%
+7,820
New +$529K
D icon
62
Dominion Energy
D
$60B
$548K 0.27%
7,156
-1,018
-12% -$75K
AMT icon
63
American Tower
AMT
$78.3B
$487K 0.24%
+4,610
New +$501K
MRK icon
64
Merck
MRK
$317B
$480K 0.24%
8,543
ABT icon
65
Abbott
ABT
$183B
$453K 0.23%
11,790
-1,000
-8% -$39.7K
XOM icon
66
ExxonMobil
XOM
$628B
$425K 0.21%
4,705
+150
+3% +$13.1K
CERN
67
DELISTED
Cerner Corp
CERN
$422K 0.21%
8,910
-35,594
-80% -$1.89M
CTXS
68
DELISTED
Citrix Systems Inc
CTXS
$350K 0.17%
4,916
FDS icon
69
Factset
FDS
$9.89B
$345K 0.17%
2,110
+27
+1% +$4.31K
CLX icon
70
Clorox
CLX
$12.8B
$318K 0.16%
2,651
PAYX icon
71
Paychex
PAYX
$42.1B
$317K 0.16%
5,200
KNGT
72
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$289K 0.14%
8,750
NVO
73
Novo Nordisk
NVO
$197B
$266K 0.13%
14,856
-123,152
-89% -$2.23M
TRMB icon
74
Trimble
TRMB
$13.7B
$248K 0.12%
8,225
-823
-9% -$23.6K
XEC
75
DELISTED
CIMAREX ENERGY CO
XEC
$238K 0.12%
1,750
-250
-13% -$33.5K

Similar funds

Carderock Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Carderock Capital Management held 83 positions worth $201M, up 0.39% from $200M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Carderock Capital Management's Q4 2016 filing shows 5 new, 29 increased, 36 reduced and 6 closed positions. Its largest new stake was Meta Platforms (Facebook): 10,631 shares worth $1.22M. The largest sale was Novo Nordisk, an estimated $2.23M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Carderock Capital Management's largest Q4 2016 buy was Meta Platforms (Facebook): 10,631 shares worth $1.22M.
  • Carderock Capital Management added most to SLB Ltd in Q4 2016, an estimated $2.11M increase.
  • Carderock Capital Management's biggest Q4 2016 reduction was Novo Nordisk, cutting an estimated $2.23M.
  • Carderock Capital Management fully exited CVS Health in Q4 2016, selling an estimated $2.14M.
  • Carderock Capital Management's ten largest holdings make up 28% of its $201M portfolio in Q4 2016.
  • Carderock Capital Management opened 5 new positions and closed 6 in Q4 2016.
  • Carderock Capital Management's portfolio value rose 0.39% quarter-over-quarter to $201M.

Based on Carderock Capital Management's 13F filing for Q4 2016, filed 8 Feb 2017.